Kabashima K, Matsumura T, Komazaki H, Kawashima M, et al. Nemolizumab plus topical agents in patients with atopic dermatitis and moderate-to-severe pruritus provide improvement in pruritus and signs of atopic dermatitis for up to 68 weeks: results from two phase III, long-term studies. Br J Dermatol 2021 Nov 2. doi: 10.1111/bjd.20873.
PMID: 34726262